ConductScience.org, home

Paper39629124

BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN/AKT/β-catenin pathway.

Cao L and 12 others. Theranostics, 2024. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN/AKT/β-catenin pathway. Papers, record 39629124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39629124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN/AKT/β-catenin pathway.
PubMed
Journal
Theranostics
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
2.27, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cao LLonglong
2Weng KKai
3Li LLujie
4Lin GGuangtan
5Zhao YYuxuan
6Gao YYouxin
7Huang XXiaobo
8Chen QQiyue
9Wang JJiabin
10Zheng CChaohui
11Huang CChangming
12Xie JJianwei
13Li PPing

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Stomach NeoplasmsMajor topic
PTEN PhosphohydrolaseMajor topic
Neoplastic Stem CellsMajor topic
Drug Resistance, NeoplasmMajor topic
Proto-Oncogene Proteins c-aktMajor topic
Basic-Leucine Zipper Transcription FactorsMajor topic
beta CateninMajor topic
Signal TransductionMajor topic
Humans
Cell Line, Tumor
Animals
Mice
Fluorouracil
Gene Expression Regulation, Neoplastic
ATP Binding Cassette Transporter, Subfamily G, Member 2
Tumor Suppressor Proteins
Female
Xenograft Model Antitumor Assays
Male
Mice, Nude
Neoplasm Proteins

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
215803154Tumour stem cells and drug resistance.Nat Rev Cancer2005https://conductscience.org/library/papers/15803154PubMed
320531301Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1.Oncogene2010https://conductscience.org/library/papers/20531301PubMed
431110221Methylation and PTEN activation in dental pulp mesenchymal stem cells promotes osteogenesis and reduces oncogenesis.Nat Commun2019https://conductscience.org/library/papers/31110221PubMed
525957166Batf2/Irf1 induces inflammatory responses in classically activated macrophages, lipopolysaccharides, and mycobacterial infection.J Immunol2015https://conductscience.org/library/papers/25957166PubMed
638997271Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway.Cell Death Dis2024https://conductscience.org/library/papers/38997271PubMed
734857912A tumour-resident Lgr5+ stem-cell-like pool drives the establishment and progression of advanced gastric cancers.Nat Cell Biol2021https://conductscience.org/library/papers/34857912PubMed
833648498CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.Mol Cancer2021https://conductscience.org/library/papers/33648498PubMed
930562741lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.Cell Physiol Biochem2018https://conductscience.org/library/papers/30562741PubMed
1028554189Structure of the human multidrug transporter ABCG2.Nature2017https://conductscience.org/library/papers/28554189PubMed
118570175B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family.Oncogene1995https://conductscience.org/library/papers/8570175PubMed
1230228301Stem cell fate in cancer growth, progression and therapy resistance.Nat Rev Cancer2018https://conductscience.org/library/papers/30228301PubMed
1335417031Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway.Oncol Rep2022https://conductscience.org/library/papers/35417031PubMed
1427353863SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin.Nat Commun2016https://conductscience.org/library/papers/27353863PubMed
1533436496PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.Gut2022https://conductscience.org/library/papers/33436496PubMed
1633671108The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter.Int J Mol Sci2021https://conductscience.org/library/papers/33671108PubMed
1737777155BATF2 inhibits PD-L1 expression and regulates CD8+ T-cell infiltration in non-small cell lung cancer.J Biol Chem2023https://conductscience.org/library/papers/37777155PubMed
1834282134Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism.Nat Commun2021https://conductscience.org/library/papers/34282134PubMed
1932650804m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling.Mol Cancer2020https://conductscience.org/library/papers/32650804PubMed
2034217777DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer.J Hepatol2021https://conductscience.org/library/papers/34217777PubMed

See all 34 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42459646Decoding the PTM code of cGAS-STING in gastric cancer: from innate DNA sensing to precision combination therapy.Front Immunol2026https://conductscience.org/library/papers/42459646PubMed
42327781CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers.Front Immunol2026https://conductscience.org/library/papers/42327781PubMed
42221812Integration of single-cell regulon atlas and bulk RNA-seq for individualized prognostic prediction in stomach adenocarcinoma.iScience2026https://conductscience.org/library/papers/42221812PubMed
41802813Hyaluronic acid-CD44 signaling defines therapeutic resistance and immunosuppressive microenvironment in peritoneal metastasis of gastric cancer.J Immunother Cancer2026https://conductscience.org/library/papers/41802813PubMed
41761192MCM10, a novel YAP1/TEAD4 target, drives gastric cancer progression by bridging DNA replication to stemness acquisition.Mol Cancer2026https://conductscience.org/library/papers/41761192PubMed
41725823Gastric cancer organoids: a promising model for personalized treatment of gastric cancer.Front Cell Dev Biol2025https://conductscience.org/library/papers/41725823PubMed
41457098BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity.Nat Commun2025https://conductscience.org/library/papers/41457098PubMed
41127013Case Report: Failed response to anti-PD-1 immunotherapy in a colon cancer patient with high microsatellite instability.Front Oncol2025https://conductscience.org/library/papers/41127013PubMed
40765835Harnessing Natural Products to Surmount Drug Resistance in Gastric Cancer: Mechanisms and Therapeutic Perspectives.Int J Biol Sci2025https://conductscience.org/library/papers/40765835PubMed
40682844Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review).Int J Oncol2025https://conductscience.org/library/papers/40682844PubMed
40279682DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer.Neoplasia2025https://conductscience.org/library/papers/40279682PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39629124

GET https://conductscience.org/api/papers/v1/39629124/references?page=2